CONSENT OF INDEPENDENT ACCOUNTANTS
Published on April 25, 1997
EXHIBIT 24.3
CONSENT OF INDEPENDENT ACCOUNTANTS
We consent to the inclusion in this Post-Effective Amendment No. 2 to
the Registration Statement on Form SB-2 of our report dated February 7, 1997
(with respect to Note K[2], February 21, 1997) on our audits of the financial
statements of Cytoclonal Pharmaceutics Inc. We also consent to the reference of
our firm under the captions "Experts" and "Selected Financial Data" in the
Prospectus.
/s/ Richard A. Eisner & Company, LLP
New York, NY
April 21, 1997